KPIs & Operating Metrics(New)
Growth Metrics

Abbott Laboratories (ABT) Debt Ratio (2016 - 2026)

Abbott Laboratories' Debt Ratio history spans 18 years, with the latest figure at 0.31 for Q1 2026.

  • On a quarterly basis, Debt Ratio rose 89.64% to 0.31 in Q1 2026 year-over-year; TTM through Mar 2026 was 0.31, a 89.64% increase, with the full-year FY2025 number at 0.15, down 14.06% from a year prior.
  • Debt Ratio hit 0.31 in Q1 2026 for Abbott Laboratories, up from 0.15 in the prior quarter.
  • Over the last five years, Debt Ratio for ABT hit a ceiling of 5.82 in Q4 2022 and a floor of 0.15 in Q4 2025.
  • Historically, Debt Ratio has averaged 0.53 across 5 years, with a median of 0.2 in 2024.
  • Biggest five-year swings in Debt Ratio: skyrocketed 134.04% in 2022 and later crashed 96.55% in 2023.
  • Tracing ABT's Debt Ratio over 5 years: stood at 5.82 in 2022, then crashed by 96.55% to 0.2 in 2023, then fell by 13.47% to 0.17 in 2024, then decreased by 14.06% to 0.15 in 2025, then soared by 106.78% to 0.31 in 2026.
  • Business Quant data shows Debt Ratio for ABT at 0.31 in Q1 2026, 0.15 in Q4 2025, and 0.15 in Q3 2025.